Free Trial
OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

Cresco Labs logo
$0.66 -0.04 (-5.49%)
As of 03:59 PM Eastern

About Cresco Labs Stock (OTCMKTS:CRLBF)

Key Stats

Today's Range
$0.65
$0.71
50-Day Range
$0.43
$0.89
52-Week Range
$0.43
$2.05
Volume
1.00 million shs
Average Volume
534,508 shs
Market Capitalization
$322.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Cresco Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

CRLBF MarketRank™: 

Cresco Labs scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cresco Labs are expected to grow in the coming year, from ($0.20) to ($0.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cresco Labs is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cresco Labs is -2.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cresco Labs has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cresco Labs' valuation and earnings.
  • Percentage of Shares Shorted

    0.14% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently decreased by 1.36%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cresco Labs does not currently pay a dividend.

  • Dividend Growth

    Cresco Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.14% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently decreased by 1.36%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cresco Labs this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cresco Labs insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.05% of the stock of Cresco Labs is held by institutions.

  • Read more about Cresco Labs' insider trading history.
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Stock News Headlines

CRLBF - Cresco Labs Inc Financials - Morningstar
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
CRLBF Cresco Labs Inc. - Seeking Alpha
See More Headlines

CRLBF Stock Analysis - Frequently Asked Questions

Cresco Labs' stock was trading at $0.9137 at the beginning of 2025. Since then, CRLBF shares have decreased by 28.1% and is now trading at $0.6574.

Cresco Labs Inc. (OTCMKTS:CRLBF) announced its quarterly earnings data on Friday, May, 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The firm had revenue of $165.76 million for the quarter, compared to the consensus estimate of $164.37 million. Cresco Labs had a negative net margin of 11.86% and a negative trailing twelve-month return on equity of 21.77%.

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/30/2025
Today
7/11/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CRLBF
CIK
1832928
Fax
N/A
Employees
2,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.44 million
Net Margins
-11.86%
Pretax Margin
-3.89%
Return on Equity
-21.77%
Return on Assets
-6.00%

Debt

Debt-to-Equity Ratio
1.63
Current Ratio
2.75
Quick Ratio
1.98

Sales & Book Value

Annual Sales
$724.34 million
Price / Sales
0.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.79 per share
Price / Book
0.83

Miscellaneous

Outstanding Shares
491,020,000
Free Float
N/A
Market Cap
$322.80 million
Optionable
Not Optionable
Beta
1.40
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:CRLBF) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners